NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1902065543 M.D.
Verify on CMS → Khashayar Hematpour, M.D.
Cardiovascular Disease Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
547
Medicare Part D claims · 185 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.4/100
▼ 1 pts below national avg 83.1 · Above neutral
Industry payments
$5.0K
126 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Khashayar Hematpour, M.D. reported a CMS MIPS final score of 82.4/100 - below the 83.1 national average - and filed 547 Medicare Part D claims in 2023.
- 82.4/100
- MIPS score · -1 vs avg
- 547
- Part D claims, 2023
- 80%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Khashayar Hematpour, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
82 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Khashayar Hematpour, M.D. sits
This provider among cardiovascular disease physician peers
Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Khashayar Hematpour, M.D. writes more Part D claims than 15% of them and scores higher on MIPS quality than 41% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Khashayar Hematpour, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Khashayar Hematpour, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Khashayar Hematpour, M.D.?
Near national averagePrimary specialty
Cardiovascular Disease Physician
Medicare Part D claims
547 82% vs specialty avg
MIPS final score
82.4/100 0.7 pts vs avg
Specialty distribution in Massachusetts
How Cardiovascular Disease Physician compares to other specialties among Massachusetts providers
Medicare quality performance, MIPS
Khashayar Hematpour, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 82.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) - 82.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Khashayar Hematpour, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 732 HARRISON AVE, Boston, MA, 02118, with a listed phone of (617) 638-7490. NPI 1902065543 was issued on 06/09/2008.
Medicare Part D records for calendar year 2023 show 547 prescription claims written by this provider, covering 185 Medicare beneficiaries and totaling roughly $123K in drug spend, split 20% brand-name and 80% generic by claim count, with an opioid prescribing rate of 3.8%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.4/100 for the 2023 performance year (Quality 79.2, Cost 58.5), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,810 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1902065543 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/09/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
82.3883
Final Score
Avg: 83.1
79.2344
Quality
58.5062
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Khashayar Hematpour, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
UT Physicians
Pearland, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Khashayar Hematpour, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$5.0K
Largest payer
Biosense Webster, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Khashayar Hematpour, M.D.. To verify Khashayar Hematpour, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Khashayar Hematpour, M.D. - brand share 20.0%
Cardiovascular Disease Physician average
20% brand-name claims vs 80% generic, on 547 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
547
Total Claims
$123K
Total Drug Cost
185
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,093
- Total Day Supply
- 31,218
- Brand vs Generic
- 20% brand / 80% generic
- Brand Drug Cost
- $106K
- Generic Drug Cost
- $17K
- Opioid Claims
- 21 (3.8% rate)
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 2.09
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 13, 65-74: 84, 75-84: 73, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Khashayar Hematpour, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
79 claims
- Eliquis
Eliquis
62 claims
- Amiodarone Hcl
Amiodarone Hcl
47 claims
- Xarelto
Xarelto
35 claims
- Minocycline Hcl 25
Minocycline Hcl
25 claims
- Clopidogrel 24
Clopidogrel
24 claims
- Furosemide 24
Furosemide
24 claims
- Acetaminophen-Code… 21
Acetaminophen-Codeine
21 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 79 |
| Eliquis Apixaban | 62 |
| Amiodarone Hcl | 47 |
| Xarelto Rivaroxaban | 35 |
| Minocycline Hcl | 25 |
| Clopidogrel Clopidogrel Bisulfate | 24 |
| Furosemide | 24 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 21 |
| Flecainide Acetate | 20 |
| Metoprolol Tartrate | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Cardiovascular Disease Physician in MA →
All providers in Massachusetts →
Compare specialties →
Cardiovascular Disease Physician Overview
How Khashayar Hematpour, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
24,810
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Khashayar Hematpour, M.D.'s 547 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Hematpour.
Dr. Omar Abdel-Razek
MD
Boston, MA
Abdelrhman Abumoawad
Boston, MA
Dr. Kenneth Adams
M.D.
Haverhill, MA
Dr. Dale Adler
M.D.
Boston, MA
Dr. Nadeem Afridi
MD
Newburyport, MA
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Massachusetts
Frequently Asked Questions
What is Khashayar Hematpour, M.D.'s specialty? ▼
Khashayar Hematpour, M.D. specializes in Cardiovascular Disease Physician and practices in Boston, Massachusetts. Credentials: M.D..
How much does Khashayar Hematpour, M.D. prescribe under Medicare Part D? ▼
In 2023, Khashayar Hematpour, M.D. wrote 547 Medicare Part D claims totaling $123K in drug costs for 185 beneficiaries.
What is Khashayar Hematpour, M.D.'s Medicare quality score? ▼
Khashayar Hematpour, M.D. has a CMS MIPS Final Score of 82.4/100 (Quality: 79.2, Cost: 58.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Khashayar Hematpour, M.D. located? ▼
Khashayar Hematpour, M.D. is located at 732 HARRISON AVE, Boston, MA, 02118. Phone: (617) 638-7490.
What is Khashayar Hematpour, M.D.'s NPI number? ▼
Khashayar Hematpour, M.D.'s National Provider Identifier (NPI) is 1902065543, issued on 06/09/2008.
Does Khashayar Hematpour, M.D. prescribe more brand-name or generic drugs? ▼
Khashayar Hematpour, M.D.'s prescribing is 20% brand-name and 80% generic drugs by claim count, with $106K in brand drug costs.
Does Khashayar Hematpour, M.D. prescribe opioids? ▼
Yes, Khashayar Hematpour, M.D. had 21 opioid claims in 2023 with an opioid prescribing rate of 3.8%.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,810 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Khashayar Hematpour, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Khashayar Hematpour, M.D.'s most frequently prescribed drugs include Metoprolol Succinate, Eliquis, Amiodarone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Khashayar Hematpour, M.D. accept Medicare? ▼
Khashayar Hematpour, M.D. appears in CMS Medicare data with 547 Part D claims and 185 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Khashayar Hematpour, M.D.'s credentials? ▼
Khashayar Hematpour, M.D.'s NPI is 1902065543 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.